Myalgic Encephalomyelitis: Clinical Trials

9 trials for Myalgic Encephalomyelitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 9 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 29Completed 5, Terminated 2, Active not recruiting 1, Recruiting 1
Phase 12Completed 1, Recruiting 1

Follow Myalgic Encephalomyelitis: new trials by email Literature Review of Myalgic Encephalomyelitis trials Research Report on Myalgic Encephalomyelitis

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Lumbrokinase - Long Covid, Post-treatment Lyme Disease Syndrome
Phase 1 / Phase 2RecruitingIcahn School of Medicine at Mount Sinai1202024-10-092026-03-13
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
NAC 900mg/day, NAC 3600mg/day, NAC 0mg/day (Placebo) - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 2Active not recruitingWeill Medical College of Cornell University952020-09-012026-06-22
The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
Pyridostigmine Bromide, Placebo - Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Chronic Fatigue Syndrome
Phase 2CompletedBrigham and Women's Hospital452020-01-142022-11-08
The Comeback Study
Preprocessed thawed donor FMT, Preprocessed thawed autologous FMT - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 2CompletedUniversity Hospital of North Norway802019-02-152024-02-23
Clinical Trial to Investigate CT38 in the Treatment of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
CT38 - Myalgic Encephalomyelitis, Chronic Fatigue Syndrome
Phase 1 / Phase 2CompletedLUCINDA BATEMAN, MD172018-07-232020-05-12
Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome
Etanercept - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 2TerminatedHaukeland University Hospital42012-10-012015-12-02
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome
Rituximab - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 2CompletedHaukeland University Hospital292010-10-012014-09-01
B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome
Rituximab - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 2TerminatedHaukeland University Hospital82010-06-012024-03-04
The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial
Clonidine, Lactose capsula - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
Phase 2CompletedOslo University Hospital1202010-02-012012-11-20

Narrower conditions

Fatigue Syndrome, Chronic (9)  ·  Autonomic Nervous System Diseases (1)  ·  Fatigue (1)  ·  Fibromyalgia (1)  ·  Hypotension, Orthostatic (1)  ·  Lyme Disease (1)  ·  Post-Acute COVID-19 Syndrome (1)  ·  Post-Lyme Disease Syndrome (1)  ·  Postural Orthostatic Tachycardia Syndrome (1)

Broader conditions

Chronic Disease (9)  ·  Disease Attributes (9)  ·  Encephalomyelitis (9)  ·  Muscular Diseases (9)  ·  Musculoskeletal Diseases (9)  ·  Nervous System Diseases (9)  ·  Neuroinflammatory Diseases (9)  ·  Neuromuscular Diseases (9)  ·  Pathologic Processes (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Borrelia Infections (1)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)

Interventions

Rituximab (2)  ·  Clonidine (1)  ·  Etanercept (1)  ·  Pyridostigmine Bromide (1)  ·  lumbrokinase (1)  ·  microcrystalline cellulose (1)

Sponsors

Haukeland University Hospital (3)  ·  Brigham and Women's Hospital (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  LUCINDA BATEMAN, MD (1)  ·  Oslo University Hospital (1)  ·  University Hospital of North Norway (1)  ·  Weill Medical College of Cornell University (1)

Countries

Norway (5)  ·  United States (4)

Top investigators

Olav Mella, PhD, MD (2)  ·  David Putrino, PhD, PT (1)  ·  David Systrom, MD (1)  ·  Dikoma C. Shungu, Ph.D. (1)  ·  Lucinda Bateman, MD (1)  ·  Rasmus Goll, MD. PhD. (1)  ·  Suzanne D Vernon, PhD (1)  ·  Vegard Bruun Wyller, MD, PhD (1)

Results publications

PMID 26132314, PMID 22871021, PMID 24493300, PMID 25287104, PMID 26357864, PMID 27149955, PMID 28494812, PMID 29202780, PMID 33516248, PMID 34539356, PMID 35526605, PMID 38858151

NIH funding

R01NS116887 (1)